The digital health field continues to boom as SoftBank-backed startup hits unicorn status in SPAC reverse merger

Editor’s note: Interested in following biopharma’s fast-paced IPO market? You can bookmark our IPO Tracker here.

At the intersection of medicine and cutting-edge technology, the broad field of digital health has seen booming valuations in recent months with some big-name investors jumping in. Now, a company working on software-based therapeutics...

Click to view original post